Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US OptionsDetailed Quotes
VXRT250516C1000
- 0.04
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.04Open0.04Pre Close0 Volume285 Open Interest1.00Strike Price0.00Turnover419.53%IV131.63%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.2646Delta0.9307Gamma11.24Leverage Ratio-0.0046Theta0.0000Rho2.97Eff Leverage0.0003Vega
Vaxart Newsroom
B.Riley Financial Maintains Vaxart(VXRT.US) With Buy Rating, Cuts Target Price to $2
Vaxart Analyst Ratings
B. Riley Securities Maintains Buy on Vaxart, Lowers Price Target to $2
B. Riley Cuts Price Target on Vaxart to $2 From $2.50, Keeps Buy Rating
Oppenheimer Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $4
Oppenheimer Sticks to Their Buy Rating for Vaxart (VXRT)
Oppenheimer Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $4
B.Riley Financial Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $2.5
Vaxart's Promising Advancements in Oral Vaccine Development and Norovirus Program Drive Buy Rating
Oppenheimer Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $4
Vaxart (VXRT) Receives a Buy From Oppenheimer
Oppenheimer Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $4
Oppenheimer Sticks to Their Buy Rating for Vaxart (VXRT)
B.Riley Financial Maintains Vaxart(VXRT.US) With Buy Rating, Maintains Target Price $2.5
Oppenheimer Initiates Vaxart at Outperform With $4 Price Target
Vaxart Analyst Ratings
Buy Rating Affirmed for Vaxart Amidst Promising Norovirus Vaccine Developments and Market Opportunity
B. Riley Raises Price Target on Vaxart to $2.50 From $2, Maintains Buy Rating
Vaxart Analyst Ratings
Analysts' Top Healthcare Picks: Vaxart (VXRT), Palisade Bio (PALI)
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
